Literature DB >> 33855698

Immune thrombocytopenia during the COVID-19 pandemic.

Eun-Ju Lee1, Xinguang Liu2, Ming Hou2, James B Bussel3.   

Abstract

Entities:  

Year:  2021        PMID： 33855698     DOI： 10.1111/bjh.17457

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

1.  Clinical Implication of the Effect of the Production of Neutralizing Antibodies Against SARS-Cov-2 for Chronic Immune Thrombocytopenia Flare-Up Associated with COVID-19 Infection: A Case Report and the Review of Literature.

Authors:  Chika Maekura; Ayako Muramatsu; Hiroaki Nagata; Haruya Okamoto; Akio Onishi; Daishi Kato; Reiko Isa; Takahiro Fujino; Taku Tsukamoto; Shinsuke Mizutani; Yuji Shimura; Tsutomu Kobayashi; Keita Okumura; Tohru Inaba; Yoko Nukui; Junya Kuroda
Journal:  Infect Drug Resist       Date:  2022-05-31       Impact factor: 4.177

2.  Real-world, single-center experience of SARS-CoV-2 vaccination in immune thrombocytopenia.

Authors:  Philippa Woolley; Anish Tailor; Raakhee Shah; John-Paul Westwood; Marie Scully
Journal:  J Thromb Haemost       Date:  2022-04-05       Impact factor: 16.036

3.  Safety of anti-SARS-CoV-2 vaccination for patients with immune thrombocytopenia.

Authors:  Etienne Crickx; Guillaume Moulis; Mikael Ebbo; Louis Terriou; Antoine Briantais; Laetitia Languille; Nicolas Limal; Stéphanie Guillet; Marc Michel; Matthieu Mahevas; Bertrand Godeau
Journal:  Br J Haematol       Date:  2021-08-31       Impact factor: 6.998

4.  Diagnosis of immune thrombocytopenia, including secondary forms, and selection of second-line treatment.

Authors:  James B Bussel; Christine A Garcia
Journal:  Haematologica       Date:  2022-09-01       Impact factor: 11.047
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.